Loading...
XSHG600381
Market cap262mUSD
Dec 25, Last price  
3.29CNY
1D
-1.79%
1Q
14.24%
Jan 2017
-78.66%
Name

Qinghai Spring Medicinl Rsrcs Tech CoLTD

Chart & Performance

D1W1MN
XSHG:600381 chart
P/E
P/S
8.95
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
0.41%
Rev. gr., 5y
-8.48%
Revenues
214m
+33.52%
990,498,358585,280,37786,416,7569,602,51840,721,64453,030,61761,371,358238,803,643514,260,5994,167,45829,902,5251,401,689,319708,130,160471,117,193333,018,482233,746,329124,266,266127,764,006160,178,078213,876,676
Net income
-268m
18,861,5850050,731,273117,046,28951,462,06953,582,58592,611,641032,859,87979,356,632357,575,992244,960,927310,542,22468,446,8595,807,775000-267,865,267
CFO
24m
33,828,361162,116,15221,566,8446,996,11420,828,46439,161,46071,473,341249,975,574000832,165,160344,988,73495,735,9280000023,916,780
Dividend
May 21, 20030.052371 CNY/sh

Profile

Qinghai Spring Medicinal Resources Technology Co., Ltd. research and development, production, and sale of cordyceps products. It is also involved in the sale of beverages and aquatic products; advertising; and foreign investment business. The company was founded in 2003 and is based in Xining, China.
IPO date
May 08, 2001
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
213,877
33.52%
160,178
25.37%
127,764
2.81%
Cost of revenue
288,047
235,189
179,811
Unusual Expense (Income)
NOPBT
(74,171)
(75,011)
(52,047)
NOPBT Margin
Operating Taxes
5,930
Tax Rate
NOPAT
(80,101)
(75,011)
(52,047)
Net income
(267,865)
 
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
1,950
549
Long-term debt
19,668
5,891
1,155
Deferred revenue
1,628
2,358
Other long-term liabilities
1,016
1
1
Net debt
(242,263)
(389,819)
(434,198)
Cash flow
Cash from operating activities
23,917
CAPEX
(13,531)
(121,794)
Cash from investing activities
36,159
48,660
Cash from financing activities
(8,531)
(895)
FCF
29,469
84,565
89,996
Balance
Cash
172,930
169,347
199,586
Long term investments
89,001
228,313
236,316
Excess cash
251,237
389,651
429,514
Stockholders' equity
923,359
1,295,557
1,583,106
Invested Capital
1,026,931
1,149,740
1,394,266
ROIC
ROCE
EV
Common stock shares outstanding
582,316
587,061
587,061
Price
7.73
-37.21%
12.31
46.03%
8.43
-2.09%
Market cap
4,501,301
-37.71%
7,226,718
46.03%
4,948,922
-2.09%
EV
4,261,290
6,836,899
4,514,724
EBITDA
(44,376)
(33,500)
(10,032)
EV/EBITDA
Interest
962
92
52
Interest/NOPBT